Tauroursodeoxycholic acid

Tauroursodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Tauroursodeoxycholic acid is associated with abnormalities such as Hyperglycemia, Obesity, Wiskott-Aldrich Syndrome, neurogenic hypertension and Cholestatic liver disease. The involved functions are known as Cell Death, Apoptosis, Homeostasis, Process and mRNA Expression. Tauroursodeoxycholic acid often locates in Body tissue, Endoplasmic Reticulum, Hepatic, Blood and Protoplasm. The associated genes with Tauroursodeoxycholic acid are Homologous Gene and Mutant Proteins. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Tauroursodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid is suspected in Endothelial dysfunction, Hyperglycemia, Obesity, neurogenic hypertension, Cholestatic liver disease, Heart failure and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tauroursodeoxycholic acid

MeSH term MeSH ID Detail
Insulin Resistance D007333 99 associated lipids
Hypertension D006973 115 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with Tauroursodeoxycholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tauroursodeoxycholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tauroursodeoxycholic acid?

Disease model

Disease model are used in the study 'Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.' (Cortez LM et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tauroursodeoxycholic acid

Download all related citations
Per page 10 20 50 100 | Total 531
Authors Title Published Journal PubMed Link
Walsh LK et al. Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load. 2016 Clin. Sci. pmid:27503949
Chen W et al. Bile acids for viral hepatitis. 2003 Cochrane Database Syst Rev pmid:12804455
Chen W and Gluud C Bile acids for liver-transplanted patients. 2005 Cochrane Database Syst Rev pmid:16034975
Sökmen HM et al. Situs inversus totalis and secondary biliary cirrhosis: a case report. 2011 Comp Hepatol pmid:21813017
Luoma PV Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia. 2011 Curr. Mol. Med. pmid:21568932
Xiao C et al. Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and beta-cell dysfunction in humans. 2011 Diabetes pmid:21270237
Ye R et al. Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance. 2010 Diabetes pmid:19808896
Zhou L et al. DsbA-L alleviates endoplasmic reticulum stress-induced adiponectin downregulation. 2010 Diabetes pmid:20699416
Miki T et al. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition. 2009 Diabetes pmid:19755525
Kars M et al. Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. 2010 Diabetes pmid:20522594
Xie C et al. An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice. 2017 Diabetes pmid:28223344
Cheang WS et al. PPARδ Is Required for Exercise to Attenuate Endoplasmic Reticulum Stress and Endothelial Dysfunction in Diabetic Mice. 2017 Diabetes pmid:27856609
Contreras C et al. Reduction of Hypothalamic Endoplasmic Reticulum Stress Activates Browning of White Fat and Ameliorates Obesity. 2017 Diabetes pmid:27634226
Raciti GA et al. Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells. 2010 Diabetologia pmid:20165829
Tang C et al. Glucose-induced beta cell dysfunction in vivo in rats: link between oxidative stress and endoplasmic reticulum stress. 2012 Diabetologia pmid:22396011
Yung HW et al. Placental endoplasmic reticulum stress in gestational diabetes: the potential for therapeutic intervention with chemical chaperones and antioxidants. 2016 Diabetologia pmid:27406815
Panzhinskiy E et al. Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubes. 2013 Diabetologia pmid:23178931
Piazza F et al. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid. 2000 Dig Liver Dis pmid:11515630
Miyake H et al. Partial characterization of mechanisms of cytoprotective action of hydrophilic bile salts against hydrophobic bile salts in rats: relation to canalicular membrane fluidity and packing density. 1999 Dig. Dis. Sci. pmid:9952244
Muraca M et al. Protective effect of tauroursodeoxycholate against acute gastric mucosal injury induced by hydrophobic bile salts. 1996 Dig. Dis. Sci. pmid:8654150
Komichi D et al. Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes. 2003 Dig. Dis. Sci. pmid:14714619
Petruzzelli M et al. Indomethacin enhances bile salt detergent activity: relevance for NSAIDs-induced gastrointestinal mucosal injury. 2006 Dig. Dis. Sci. pmid:16615001
Ono T et al. Tauroursodeoxycholic acid protects cholestasis in rat reperfused livers: its roles in hepatic calcium mobilization. 1998 Dig. Dis. Sci. pmid:9790455
Crosignani A et al. Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study. 1996 Dig. Dis. Sci. pmid:8674405
Takikawa H et al. Effects of ursodeoxycholate and its conjugates on biliary glutathione excretion in rats. 1996 Dig. Dis. Sci. pmid:8888706
Cho EJ et al. Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet. 2014 Dig. Dis. Sci. pmid:24865256
Walker S et al. Absorption of urso- and chenodeoxycholic acid and their taurine and glycine conjugates in rat jejunum, ileum, and colon. 1985 Digestion pmid:4018444
Liu F et al. Tauroursodeoxycholic acid attenuates inorganic phosphate-induced osteoblastic differentiation and mineralization in NIH3T3 fibroblasts by inhibiting the ER stress response PERK-eIF2α-ATF4 pathway. 2015 Drug Discov Ther pmid:25788050
Crocenzi FA et al. Galactosamine prevents ethinylestradiol-induced cholestasis. 2006 Drug Metab. Dispos. pmid:16554370
Balandraud-Pieri N et al. Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats. 1997 Drug Metab. Dispos. pmid:9280397
Crocenzi FA et al. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat. 2005 Drug Metab. Dispos. pmid:15843489
Achard CS and Laybutt DR Lipid-induced endoplasmic reticulum stress in liver cells results in two distinct outcomes: adaptation with enhanced insulin signaling or insulin resistance. 2012 Endocrinology pmid:22374970
Kohli R et al. A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. 2013 Endocrinology pmid:23592746
van de Heijning BJ et al. Membrane cholesterol content of cholesterol/phospholipid vesicles determines the susceptibility to both damage and protection by bile salts: implications for bile physiology. 1997 Eur J Gastroenterol Hepatol pmid:9187880
Glasova H et al. Tauroursodeoxycholic acid mobilizes alpha-PKC after uptake in human HepG2 hepatoma cells. 2002 Eur. J. Clin. Invest. pmid:12059989
Benz C et al. Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. 2000 Eur. J. Clin. Invest. pmid:10691996
Aldini R et al. Hepatic uptake and intestinal absorption of bile acids in the rabbit. 1994 Eur. J. Clin. Invest. pmid:7851470
Van Erpecum KJ et al. Effects of bile salt hydrophobicity on crystallization of cholesterol in model bile. 1996 Eur. J. Clin. Invest. pmid:8864423
Benz C et al. Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes. 1998 Eur. J. Clin. Invest. pmid:9726039
Elia AE et al. Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. 2016 Eur. J. Neurol. pmid:25664595
Ishizaki K et al. Effect of sodium tauroursodeoxycholate on phalloidin-induced cholestasis in rats. 2001 Eur. J. Pharmacol. pmid:11408049
Ma J et al. Ursodeoxycholic acid inhibits endothelin-1 production in human vascular endothelial cells. 2004 Eur. J. Pharmacol. pmid:15556138
Ma J et al. Inhibitory effects of ursodeoxycholic acid on the induction of nitric oxide synthase in vascular smooth muscle cells. 2003 Eur. J. Pharmacol. pmid:12620498
Ishizaki K et al. Effect of sodium tauroursodeoxycholate (UR-906) on liver dysfunction in bile duct-ligated rats. 1997 Eur. J. Pharmacol. pmid:9314037
Cheng F et al. Refined Qingkailing Protects MCAO Mice from Endoplasmic Reticulum Stress-Induced Apoptosis with a Broad Time Window. 2012 Evid Based Complement Alternat Med pmid:22536287
Balasubramanyam M et al. Molecular intricacies and the role of ER stress in diabetes. 2012 Exp Diabetes Res pmid:22701473
Lenin R et al. Amelioration of glucolipotoxicity-induced endoplasmic reticulum stress by a "chemical chaperone" in human THP-1 monocytes. 2012 Exp Diabetes Res pmid:22550476
Beriault DR and Werstuck GH The role of glucosamine-induced ER stress in diabetic atherogenesis. 2012 Exp Diabetes Res pmid:22474416
Xu J et al. Endoplasmic reticulum stress and diabetic cardiomyopathy. 2012 Exp Diabetes Res pmid:22144992
Guo Q et al. Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice. 2017 Exp. Biol. Med. (Maywood) pmid:27811171
Nebe B et al. Induction of a physical linkage between integrins and the cytoskeleton depends on intracellular calcium in an epithelial cell line. 1996 Exp. Cell Res. pmid:8940254
van Heumen BW et al. Celecoxib and tauro-ursodeoxycholic acid co-treatment inhibits cell growth in familial adenomatous polyposis derived LT97 colon adenoma cells. 2012 Exp. Cell Res. pmid:22366264
Zhu Q et al. Tauroursodeoxycholate, a chemical chaperone, prevents palmitate-induced apoptosis in pancreatic β-cells by reducing ER stress. 2013 Exp. Clin. Endocrinol. Diabetes pmid:22972029
Kim YH and Shin MJ Effects of high taurocholate load on activities of hepatic alcohol metabolizing enzymes. 2002 Exp. Mol. Med. pmid:12085987
Keene CD et al. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. 2001 Exp. Neurol. pmid:11573988
Danchenko E et al. Effect of bile acids on the proliferative activity and apoptosis of rat hepatocytes. 2001 Exp. Toxicol. Pathol. pmid:11484843
Barth A et al. Bile acid transport and metabolism in rat liver slices. 2006 Exp. Toxicol. Pathol. pmid:16413764
Yang Z et al. Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling. 2015 FEBS J. pmid:25611565
da-Silva WS et al. The chemical chaperones tauroursodeoxycholic and 4-phenylbutyric acid accelerate thyroid hormone activation and energy expenditure. 2011 FEBS Lett. pmid:21237159
Sreejayan N and von Ritter C Effect of bile acids on lipid peroxidation: the role of iron. 1998 Free Radic. Biol. Med. pmid:9655521
Ge W et al. Cardiac-specific overexpression of catalase attenuates paraquat-induced myocardial geometric and contractile alteration: role of ER stress. 2010 Free Radic. Biol. Med. pmid:20937379
Brites D The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation. 2012 Front Pharmacol pmid:22661946
Noé J et al. Functional expression of the canalicular bile salt export pump of human liver. 2002 Gastroenterology pmid:12404240
Häussinger D et al. Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis. 2003 Gastroenterology pmid:12730886
Beuers U et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. 1996 Gastroenterology pmid:8613063
Setchell KD et al. Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. 1997 Gastroenterology pmid:8978363
Kubitz R et al. Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase. 2004 Gastroenterology pmid:14762791
Groen AK et al. Regulation of protein secretion into bile: studies in mice with a disrupted mdr2 p-glycoprotein gene. 1995 Gastroenterology pmid:7498666
Rodrigues CM et al. Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate. 1995 Gastroenterology pmid:7615207
Neuman MG et al. Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line. 1995 Gastroenterology pmid:7615206
Kurz AK et al. Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats. 2001 Gastroenterology pmid:11487550
Graf D et al. Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. 2002 Gastroenterology pmid:11984527
Beuers U et al. Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes. 1993 Gastroenterology pmid:8425704
Reinehr R et al. Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. 2003 Gastroenterology pmid:12949729
Schliess F et al. Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. 1997 Gastroenterology pmid:9322526
Milkiewicz P et al. Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways. 2002 Gut pmid:12077103
Wimmer R et al. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver. 2008 Gut pmid:18583398
Setchell KD et al. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. 1996 Gut pmid:8675100
Farrell GC et al. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. 2012 Gut Liver pmid:22570745
Tsuboi K et al. Hydrophilic bile salts have a cytoprotective effect against cyclosporine A-induced cholestasis through enhanced canalicular membrane fluidity and transporter activity. 2003 Hepatol. Res. pmid:12644037
Alvaro D et al. Functional and ultrastructural features of ethanol/bile salts interaction in the isolated perfused rat liver. 1995 Hepatology pmid:7705787
Aldini R et al. Uptake of bile acids by perfused rat liver: evidence of a structure-activity relationship. 1989 Hepatology pmid:2807164
Roda A et al. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat. 1998 Hepatology pmid:9462652
Angelico M et al. N-ethyl-tauroursodeoxycholic acid, a novel deconjugation-resistant bile salt analogue: effects of acute feeding in the rat. 1995 Hepatology pmid:7657297
Cruz LN et al. Regulation of multidrug resistance-associated protein 2 by calcium signaling in mouse liver. 2010 Hepatology pmid:20578149
Milkiewicz P et al. Tauroursodeoxycholate and S-adenosyl-L-methionine exert an additive ameliorating effect on taurolithocholate-induced cholestasis: a study in isolated rat hepatocyte couplets. 1999 Hepatology pmid:9918924
Hofmann AF Medical treatment of cholesterol gallstones by bile desaturating agents. 1984 Sep-Oct Hepatology pmid:6384003
Invernizzi P et al. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. 1999 Hepatology pmid:9918905
Dent P et al. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes. 2005 Hepatology pmid:16317705
Rodríguez-Ortigosa CM et al. Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat. 2010 Hepatology pmid:20683964
Krähenbühl S et al. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria. 1994 Hepatology pmid:7982660
Stiehl A et al. Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients. 1984 Jan-Feb Hepatology pmid:6693062
Beuers U β1 integrin is a long-sought sensor for tauroursodeoxycholic acid. 2013 Hepatology pmid:23456677
Meier PJ et al. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. 1997 Hepatology pmid:9398014
Beuers U et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. 2001 Hepatology pmid:11343250
Xie Q et al. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. 2002 Hepatology pmid:12198651
Chignard N et al. Bile acid transport and regulating functions in the human biliary epithelium. 2001 Hepatology pmid:11230727
Wang L et al. Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition. 2005 Hepatology pmid:15861431
Utili R et al. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts. 1990 Hepatology pmid:2347547
Hillaire S et al. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture. 1995 Hepatology pmid:7601437